Llew Mills

Dr. Llew Mills is a researcher in Addiction Medicine at the University of Sydney's Central Clinical School, affiliated with the South Eastern Sydney Local Health District. His work focuses on drug and alcohol treatment, particularly exploring how beliefs influence withdrawal symptoms and advancing statistical methods in behavioral analysis. He leads projects like the Cannabis as Medicine Survey (CAMS) and has contributed to randomized trials evaluating treatments for cannabis and alcohol dependence. His statistical expertise spans mixed-effects models, Bayesian analysis, and machine learning.

• Education: Ph.D. in experimental psychology with focus on caffeine withdrawal mechanisms
• Roles: Statistical Consultant for DACRIN, Researcher at Langton Centre
• Key Projects: Nabiximols clinical trials, COQI Project, Exercise & Cannabis Withdrawal RCT

Research interests include addiction causation, placebo/nocebo effects, and improving statistical rigor in behavioral research. His publications span addiction treatment outcomes, cannabis policy analysis, and psychopharmacology. Awards include the 2017 Society for Interdisciplinary Placebo Studies Travel Award and an Australian Postgraduate Award (2013-2016).

Media engagements include ABC News, Healthline, and international radio discussions on caffeine withdrawal and medical cannabis trends. Technical skills include advanced R/Python programming and Redcap survey design.